|
|
|
LifeScienceHistory.com - Check us out on Instagram
Take Your Next Career Step with Lundback
Massachusetts Life Science Industry Directory
Banner Advertising
Please note that we have a new site: LifeScienceHistory.com, "Where history is made daily" under development and
delayed by COVID-19, to be launched in 2023 replacing MassachusettsLifeScience.com. Regrettably, we are working with reduced
staffing and the current industry directory is no longer being maintained, but will be replaced with a new and improved
directory upon the launch of the new site. We apologize for the inconvenience.
Cynosure, Inc
| | | Phone: | (978) 256-4200 | Fax: | (978) 256-6556 | Year Established: | 1991 | Ticker: | HOLX | Exchange: | NASDAQ | Main Contact: | Michael Davin, Chairman, CEO & President | | Other Contacts: | Stephen J. Webber, CFO Rafael Sierra, CTO John Lenihan, VP, International Distribution David Mackie, VP, Operations Douglas J. Delaney, CCO
| | Company Description | Cynosure, a Hologic subsidiary, develops and markets aesthetic treatment systems that are used by physicians and other practitioners to perform non-invasive and minimally invasive procedures to remove hair, treat vascular and pigmented lesions, rejuvenate the skin, liquefy and remove unwanted fat through laser lipolysis and temporarily reduce the appearance of cellulite. Cynosure's products include a broad range of laser and other light-based energy sources, including Alexandrite, pulsed dye, Nd:YAG and diode lasers, as well as intense pulsed light.
On March 22 2017, Hologic announced it had completed the acquisition of Cynosure for $66 per share in cash, which corresponds to an equity value of $1.65 billion and an enterprise value of $1.44 billion net of cash. | |
|
|
|
|
|